Creative Planning
ENZN

Creative Planning’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

Creative Planning’s Portfolio ENZN Stock Details ENZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-300
Closed – – 4563
2014
Q4 		$0 Hold
300
– – ﹤0.01% 4497
2014
Q3 		$0 Hold
300
– – ﹤0.01% 4284
2014
Q2 		$0 Hold
300
– – ﹤0.01% 4092
2014
Q1 		$0 Hold
300
– – ﹤0.01% 3874
2013
Q4 		$0 Hold
300
– – ﹤0.01% 3594
2013
Q3 		$1K Hold
300
– – ﹤0.01% 3160
2013
Q2 		$1K Buy
+300
New +$878 ﹤0.01% 3020

Other funds holding ENZN

IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Creative Planning's ENZN Position: Q1 2015 in Review

Creative Planning sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q1 2015, closing a stake of 300 shares.

Creative Planning first reported a position in ENZN in Q2 2013 and held it in 7 quarters. The position peaked at $1K in Q3 2013. 53 funds tracked by Wall St. Rank hold ENZN as of Q1 2015.

  • Creative Planning reported no remaining ENZON PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • Creative Planning sold 300 ENZON PHARMACEUTICALS INC shares in Q1 2015.
  • Creative Planning first reported a position in ENZON PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • Creative Planning's ENZON PHARMACEUTICALS INC position peaked at $1K in Q3 2013.
  • 53 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q1 2015.

Based on Creative Planning's 13F filing for Q1 2015, filed 13 Apr 2015.